Nordic-Neurostim ApS: Financial statements 2018
CVR: 38049909
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Nordic-Neurostim ApS (CVR 38049909) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 248,597 and a net result of DKK 184,201. Equity in the 2018 report amounted to DKK 132,367. The solvency ratio was 18%.
- Gross Profit
- DKK 248,597
- Profit/Loss
- DKK 184,201
- Equity
- DKK 132,367
- Total Assets
- DKK 734,220
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Nordic-Neurostim ApS has published its interim report for the period September 28, 2016 to December 31, 2017.
About Nordic-Neurostim ApS
Nordic-Neurostim ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Christian Peter Christiansen. The board consists of Morten Kristian Haugland (chair) and Christian Peter Christiansen. The company is owned by MORTEN HAUGLAND HOLDING ApS, Varebex ApS and Medodan Consulting ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 89,658 and a net result of DKK -33,430 compared with DKK -10,264 the year before. Equity in the 2025 report amounted to DKK -1,858,514.
